Change of Name Effective

RNS Number : 6507L

Circassia Pharmaceuticals Plc

01 May 2020

 

Change of Name Effective

Oxford, UK - 1 May 2020:  Circassia Group plc ("Circassia" or "the Company"; LSE: CIR), a specialty biopharmaceutical company focused on respiratory disease, today confirms that, further to the announcement of 30 April 2020, its change of name has taken effect. The Company's TIDM remains CIR and the Company's website address continues to be www.circassia.com .

Contacts

Circassia Ian Johnson, Executive Chairman Michael Roller, Chief Financial Officer	c/o Peel Hunt
Peel Hunt (Nominated Adviser and Joint Broker) James Steel / Oliver Jackson	Tel: [phone]
finnCap (Joint Broker) Geoff Nash / Alice Lane	Tel: [phone]
Numis Securities (Joint Broker) James Black / Duncan Monteith	Tel: [phone]

 

END

 

 

CANFIFFAETILIII